iCAD slips to net losses in Q3
iCAD, a Nashua, N.H.-based developer of image analysis and workflow technologies for the identification of cancer, has reported a net loss among its third quarter financial results, which ended Sept. 30, reflecting fewer sales.
Financial highlights for the third quarter of 2010 include the following--all comparisons are with the third quarter of 2009:
Financial highlights for the third quarter of 2010 include the following--all comparisons are with the third quarter of 2009:
- Total revenue of $5.6 million, compared with $7.1 million, with international revenue of $776,000, compared with $371,000; and
- Net loss of $1.4 million, compared with net income of $113,000;
- Digital computer-aided detection (CAD) and MRI CAD revenue of $3.3 million, compared with $4.8 million;
- Film-based revenue of $748,000, compared with $1.3 million; and
- Service and supply revenue of $1.5 million, compared with $1 million.